SecBot SecBot
6-K ·Filed Oct 29, 2026

BMGL

Basel Medical Group Ltd
BEARISH
Impact 6/10
Processed45m ago SEC0001493152-26-049165
Notable filing: 6-K

Price Chart

Loading chart...

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001493152-26-049165
Document: 0001493152-26-049165-index-headers.html0001493152-26-049165
Document: 0001493152-26-049165-index.html0001493152-26-049165
Document: 0001493152-26-049165.txt0001493152-26-049165
12 reports for BMGL
Performance horizon
50% Hit rate @ T+1 2 of 4 directional calls Went positive at some point 3 of 4 best @ T+20▲ +2.45%Aug 10, 2026
Filters
Rows
Reports for BMGL, sortable and filterable
TypeNow
Oct 29, 2026
today
6-K
BEARISH ★ 6/10
$4.59awaiting T+1awaiting T+1$4.60 (−0.22%)
Oct 13, 2026
16d ago
6-K
BEARISH ★ 7/10
$3.85 $3.85· 0.00%▼ −1.08%$4.60 (−19.48%)
Oct 9, 2026
20d ago
6-K
BEARISH ★ 5/10
$3.75 $3.71▲ +1.07%▲ +1.01%$4.60 (−22.67%)
Oct 8, 2026
20d ago
424B4
BEARISH ★ 7/10
$3.75 $3.71▲ +1.07%▲ +1.01%$4.60 (−22.67%)
Sep 30, 2026
29d ago
EFFECT
NEUTRAL ★ 4/10
$3.12 $3.02▼ −3.21%▼ −3.38%$4.60 (+47.44%)
Sep 2, 2026
8w ago
6-K
NEUTRAL ★ 3/10
$4.94 $4.78▼ −3.24%▼ −4.29%$4.60 (−6.88%)
Aug 10, 2026
11w ago
6-K
BEARISH ★ 5/10
$4.90 $4.99▼ −1.84%▼ −2.16%$4.60 (+6.12%)
Jul 10, 2026
15w ago
6-K
NEUTRAL ★ 4/10
$6.61 $6.14▼ −7.04%▼ −6.27%$4.60 (−30.36%)
Jun 10, 2026
20w ago
6-K
NEUTRAL ★ 3/10
$0.5869 $0.5783▼ −1.47%▼ −3.17%$4.60 (+683.78%)
Jun 5, 2026
20w ago
6-K
NEUTRAL ★ 3/10
$0.5445 $0.5946▲ +9.20%▲ +8.97%$4.60 (+744.81%)
Showing 10 of 12

US Market Status

Market Closed · Opens in 2h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026

Fresh BMGL Intelligence

Analysis is for subscribers only.

Subscribe for Full Access